Home » Life & Medical » Research on Pulmonary Hypertension Drugs Market 2016-2020 and Forecast 2021-2026

Research on Pulmonary Hypertension Drugs Market 2016-2020 and Forecast 2021-2026

  83 Pages     Life & Medical  

Available Formats      

Report ID: 68210
Published By: 99Strategy

Summary

The Global Pulmonary Hypertension Drugs market size is estimated at xxx million USD with a CAGR xx% from 2016-2020 and is expected to reach xxx Million USD in 2021 with a CAGR xx% from 2021 to 2026. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Pulmonary Hypertension Drugs by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.

Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):

Prostacyclin and prostacyclin analogs 

Endothelin receptor antagonists (ERAs) 

Phosphodiesterase-5 (PDE-5) inhibitors 

Soluble guanylate cyclase (sGC) stimulators

Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):

Bayer 

GSK 

Arena 

Actelion 

Pfizer 

United Therapeutics 

Gilead Sciences 

Lung Biotechnology PBC

Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):

Early-stage Drug Candidates (Phase I & Phase II)

Late-stage Drug Candidates (Phase III & Registration Phase)

Region Coverage (Regional Production, Demand & Forecast by Countries etc.):

North America (U.S., Canada, Mexico)

Europe (Germany, U.K., France, Italy, Russia, Spain etc.)

Asia-Pacific (China, India, Japan, Southeast Asia etc.)

South America (Brazil, Argentina etc.)

Middle East & Africa (Saudi Arabia, South Africa etc.)

If you have any special requirements, please let us know and we will offer you the report as you want.

Table Of Contents

1 Industry Overview

1.1 Pulmonary Hypertension Drugs Industry

Figure Pulmonary Hypertension Drugs Industry Chain Structure

1.1.1 Overview

1.1.2 Development of Pulmonary Hypertension Drugs

1.2 Market Segment

1.2.1 Upstream

Table Upstream Segment of Pulmonary Hypertension Drugs

1.2.2 Downstream

Table Application Segment of Pulmonary Hypertension Drugs

Table Global Pulmonary Hypertension Drugs Market 2016-2026, by Application, in USD Million

1.2.3 COVID-19 Impact

1.3 Cost Analysis

2 Industry Environment (PEST Analysis)

2.1 Policy

2.2 Economics

2.3 Sociology

2.4 Technology

3 Pulmonary Hypertension Drugs Market by Type

3.1 By Type

3.1.1 Prostacyclin and prostacyclin analogs 

Table Major Company List of Prostacyclin and prostacyclin analogs 

3.1.2 Endothelin receptor antagonists (ERAs) 

Table Major Company List of Endothelin receptor antagonists (ERAs) 

3.1.3 Phosphodiesterase-5 (PDE-5) inhibitors 

Table Major Company List of Phosphodiesterase-5 (PDE-5) inhibitors 

3.1.4 Soluble guanylate cyclase (sGC) stimulators

Table Major Company List of Soluble guanylate cyclase (sGC) stimulators

3.2 Market Size

Table Global Pulmonary Hypertension Drugs Market 2016-2020, by Type, in USD Million

Figure Global Pulmonary Hypertension Drugs Market Growth 2016-2020, by Type, in USD Million

Table Global Pulmonary Hypertension Drugs Market 2016-2020, by Type, in Volume

Figure Global Pulmonary Hypertension Drugs Market Growth 2016-2020, by Type, in Volume

3.3 Market Forecast

Table Global Pulmonary Hypertension Drugs Market Forecast 2021-2026, by Type, in USD Million

Table Global Pulmonary Hypertension Drugs Market Forecast 2021-2026, by Type, in Volume

4 Major Companies List

4.1 Bayer  (Company Profile, Sales Data etc.)

4.1.1 Bayer  Profile

Table Bayer  Overview List

4.1.2 Bayer  Products & Services

4.1.3 Bayer  Business Operation Conditions

Table Business Operation of Bayer  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

4.2 GSK  (Company Profile, Sales Data etc.)

4.2.1 GSK  Profile

Table GSK  Overview List

4.2.2 GSK  Products & Services

4.2.3 GSK  Business Operation Conditions

Table Business Operation of GSK  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

4.3 Arena  (Company Profile, Sales Data etc.)

4.3.1 Arena  Profile

Table Arena  Overview List

4.3.2 Arena  Products & Services

4.3.3 Arena  Business Operation Conditions

Table Business Operation of Arena  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

4.4 Actelion  (Company Profile, Sales Data etc.)

4.4.1 Actelion  Profile

Table Actelion  Overview List

4.4.2 Actelion  Products & Services

4.4.3 Actelion  Business Operation Conditions

Table Business Operation of Actelion  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

4.5 Pfizer  (Company Profile, Sales Data etc.)

4.5.1 Pfizer  Profile

Table Pfizer  Overview List

4.5.2 Pfizer  Products & Services

4.5.3 Pfizer  Business Operation Conditions

Table Business Operation of Pfizer  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

4.6 United Therapeutics  (Company Profile, Sales Data etc.)

4.6.1 United Therapeutics  Profile

Table United Therapeutics  Overview List

4.6.2 United Therapeutics  Products & Services

4.6.3 United Therapeutics  Business Operation Conditions

Table Business Operation of United Therapeutics  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

4.7 Gilead Sciences  (Company Profile, Sales Data etc.)

4.7.1 Gilead Sciences  Profile

Table Gilead Sciences  Overview List

4.7.2 Gilead Sciences  Products & Services

4.7.3 Gilead Sciences  Business Operation Conditions

Table Business Operation of Gilead Sciences  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

4.8 Lung Biotechnology PBC (Company Profile, Sales Data etc.)

4.8.1 Lung Biotechnology PBC Profile

Table Lung Biotechnology PBC Overview List

4.8.2 Lung Biotechnology PBC Products & Services

4.8.3 Lung Biotechnology PBC Business Operation Conditions

Table Business Operation of Lung Biotechnology PBC (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

5 Market Competition

5.1 Company Competition

Table Global Pulmonary Hypertension Drugs Sales Revenue 2016-2020, by Company, in USD Million

Table Global Pulmonary Hypertension Drugs Sales Revenue Share 2016-2020, by Company, in USD Million

Figure Global Pulmonary Hypertension Drugs Sales Revenue Share in 2020, by Company, in USD Million

Table Global Pulmonary Hypertension Drugs Sales Volume 2016-2020, by Company, in Volume

Table Global Pulmonary Hypertension Drugs Sales Volume Share 2016-2020, by Company, in Volume

Figure Global Pulmonary Hypertension Drugs Sales Volume Share in 2020, by Company, in Volume

5.2 Regional Market by Company

Figure North America Pulmonary Hypertension Drugs Market Concentration, in 2020

Figure Europe Pulmonary Hypertension Drugs Market Market Concentration, in 2020

Figure Asia-Pacific Pulmonary Hypertension Drugs MMarket Concentration, in 2020

Figure South America Pulmonary Hypertension Drugs Market Concentration, in 2020

Figure Middle East & Africa Pulmonary Hypertension Drugs Market Concentration, in 2020

6 Demand by End Market

6.1 Demand Situation

6.1.1 Demand in Early-stage Drug Candidates (Phase I & Phase II)

Figure Pulmonary Hypertension Drugs Demand in Early-stage Drug Candidates (Phase I & Phase II), 2016-2020, in USD Million

Figure Pulmonary Hypertension Drugs Demand in Early-stage Drug Candidates (Phase I & Phase II), 2016-2020, in Volume

6.1.2 Demand in Late-stage Drug Candidates (Phase III & Registration Phase)

Figure Pulmonary Hypertension Drugs Demand in Late-stage Drug Candidates (Phase III & Registration Phase), 2016-2020, in USD Million

Figure Pulmonary Hypertension Drugs Demand in Late-stage Drug Candidates (Phase III & Registration Phase), 2016-2020, in Volume

6.2 Regional Demand Comparison

Table Regional Demand Comparison List

Table Major Application in Different Regions

6.3 Demand Forecast

Table Pulmonary Hypertension Drugs Demand Forecast 2021-2026, by Application, in USD Million

Figure Pulmonary Hypertension Drugs Market Growth 2021-2026, by Application, in USD Million

Figure Pulmonary Hypertension Drugs Market Share in 2026, by Application, in USD Million

Table Pulmonary Hypertension Drugs Demand Forecast 2021-2026, by Application, in Volume

Table Pulmonary Hypertension Drugs Market Growth 2021-2026, by Application, in Volume

Table Pulmonary Hypertension Drugs Market Share in 2026, by Application, in Volume

6.4 Impact of the COVID-19 on the Demand

7 Region Operation

7.1 Regional Production

Table Pulmonary Hypertension Drugs Production 2016-2020, by Region, in USD Million

Table Pulmonary Hypertension Drugs Production 2016-2020, by Region, in Volume

7.2 Regional Market

Table Global Pulmonary Hypertension Drugs Market 2016-2020, by Region, in USD Million

Table Global Pulmonary Hypertension Drugs Market Share 2016-2020, by Region, in USD Million

Table Global Pulmonary Hypertension Drugs Market 2016-2020, by Region, in Volume

Table Global Pulmonary Hypertension Drugs Market Share 2016-2020, by Region, in Volume

7.3 by Region

7.3.1 North America

7.3.1.1 Overview

Figure North America Pulmonary Hypertension Drugs Market Size and Growth 2016-2020, in USD Million

Figure North America Pulmonary Hypertension Drugs Market Size and Growth 2016-2020, in Volume

7.3.1.2 by Country (U.S., Canada, Mexico)

Table North America Pulmonary Hypertension Drugs Market Size 2016-2020, by Country, in USD Million

Table North America Pulmonary Hypertension Drugs Market Size 2016-2020, by Country, in Volume

7.3.2 Europe

7.3.2.1 Overview

Figure Europe Pulmonary Hypertension Drugs Market Size and Growth 2016-2020, in USD Million

Figure Europe Pulmonary Hypertension Drugs Market Size and Growth 2016-2020, in Volume

7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)

Table Europe Pulmonary Hypertension Drugs Market Size 2016-2020, by Country, in USD Million

Table Europe Pulmonary Hypertension Drugs Market Size 2016-2020, by Country, in Volume

7.3.3 Asia-Pacific

7.3.3.1 Overview

Figure Asia-Pacific Pulmonary Hypertension Drugs Market Size and Growth 2016-2020, in USD Million

Figure Asia-Pacific Pulmonary Hypertension Drugs Market Size and Growth 2016-2020, in Volume

7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)

Table Asia-Pacific Pulmonary Hypertension Drugs Market Size 2016-2020, by Country, in USD Million

Table Asia-Pacific Pulmonary Hypertension Drugs Market Size 2016-2020, by Country, in Volume

7.3.4 South America

7.3.4.1 Overview

Figure South America Pulmonary Hypertension Drugs Market Size and Growth 2016-2020, in USD Million

Figure South America Pulmonary Hypertension Drugs Market Size and Growth 2016-2020, in Volume

7.3.4.2 by Country (Brazil, Argentina etc.)

Table South America Pulmonary Hypertension Drugs Market Size 2016-2020, by Country, in USD Million

Table South America Pulmonary Hypertension Drugs Market Size 2016-2020, by Country, in Volume

7.3.5 Middle East & Africa

7.3.5.1 Overview

Figure Middle East & Africa Pulmonary Hypertension Drugs Market Size and Growth 2016-2020, in USD Million

Figure Middle East & Africa Pulmonary Hypertension Drugs Market Size and Growth 2016-2020, in Volume

7.3.5.2 by Country (Saudi Arabia, South Africa etc.)

Table Middle East & Africa Pulmonary Hypertension Drugs Market Size 2016-2020, by Country, in USD Million

Table Middle East & Africa Pulmonary Hypertension Drugs Market Size 2016-2020, by Country, in Volume

7.4 Regional Import & Export

7.5 Regional Forecast

Table Pulmonary Hypertension Drugs Market Forecast 2021-2026, by Region, in USD Million

Table Pulmonary Hypertension Drugs Market Forecast 2021-2026, by Region, in Volume

8 Marketing & Price

8.1 Price and Margin

8.1.1 Price Trends

8.1.2 Factors of Price Change

Table Price Factors List

8.1.3 Manufacturers Gross Margin Analysis

8.2 Marketing Channel

Figure Marketing Channels Overview

9 Research Conclusion

If you have any special requirements, please let us know and we will offer you the report as you want.

Fact & Figures

1. Table Upstream Segment of Pulmonary Hypertension Drugs

2. Table Application Segment of Pulmonary Hypertension Drugs

3. Table Global Pulmonary Hypertension Drugs Market 2016-2026, by Application, in USD Million

4. Table Major Company List of Endothelin receptor antagonists (ERAs) 

5. Table Major Company List of Phosphodiesterase-5 (PDE-5) inhibitors 

6. Table Major Company List of Soluble guanylate cyclase (sGC) stimulators

7. Table Global Pulmonary Hypertension Drugs Market 2016-2020, by Type, in USD Million

8. Table Global Pulmonary Hypertension Drugs Market 2016-2020, by Type, in Volume

9. Table Global Pulmonary Hypertension Drugs Market Forecast 2021-2026, by Type, in USD Million

10. Table Global Pulmonary Hypertension Drugs Market Forecast 2021-2026, by Type, in Volume

11. Table Bayer  Overview List

12. Table Business Operation of Bayer  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

13. Table GSK  Overview List

14. Table Business Operation of GSK  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

15. Table Arena  Overview List

16. Table Business Operation of Arena  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

17. Table Actelion  Overview List

18. Table Business Operation of Actelion  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

19. Table Pfizer  Overview List

20. Table Business Operation of Pfizer  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

21. Table United Therapeutics  Overview List

22. Table Business Operation of United Therapeutics  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

23. Table Gilead Sciences  Overview List

24. Table Business Operation of Gilead Sciences  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

25. Table Lung Biotechnology PBC Overview List

26. Table Business Operation of Lung Biotechnology PBC (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

27. Table Global Pulmonary Hypertension Drugs Sales Revenue 2016-2020, by Company, in USD Million

28. Table Global Pulmonary Hypertension Drugs Sales Revenue Share 2016-2020, by Company, in USD Million

29. Table Global Pulmonary Hypertension Drugs Sales Volume 2016-2020, by Company, in Volume

30. Table Global Pulmonary Hypertension Drugs Sales Volume Share 2016-2020, by Company, in Volume

31. Table Regional Demand Comparison List

32. Table Major Application in Different Regions

33. Table Pulmonary Hypertension Drugs Demand Forecast 2021-2026, by Application, in USD Million

34. Table Pulmonary Hypertension Drugs Demand Forecast 2021-2026, by Application, in Volume

35. Table Pulmonary Hypertension Drugs Market Growth 2021-2026, by Application, in Volume

36. Table Pulmonary Hypertension Drugs Market Share in 2026, by Application, in Volume

37. Table Pulmonary Hypertension Drugs Production 2016-2020, by Region, in USD Million

38. Table Pulmonary Hypertension Drugs Production 2016-2020, by Region, in Volume

39. Table Global Pulmonary Hypertension Drugs Market 2016-2020, by Region, in USD Million

40. Table Global Pulmonary Hypertension Drugs Market Share 2016-2020, by Region, in USD Million

41. Table Global Pulmonary Hypertension Drugs Market 2016-2020, by Region, in Volume

42. Table Global Pulmonary Hypertension Drugs Market Share 2016-2020, by Region, in Volume

43. Table North America Pulmonary Hypertension Drugs Market Size 2016-2020, by Country, in USD Million

44. Table North America Pulmonary Hypertension Drugs Market Size 2016-2020, by Country, in Volume

45. Table Europe Pulmonary Hypertension Drugs Market Size 2016-2020, by Country, in USD Million

46. Table Europe Pulmonary Hypertension Drugs Market Size 2016-2020, by Country, in Volume

47. Table Asia-Pacific Pulmonary Hypertension Drugs Market Size 2016-2020, by Country, in USD Million

48. Table Asia-Pacific Pulmonary Hypertension Drugs Market Size 2016-2020, by Country, in Volume

49. Table South America Pulmonary Hypertension Drugs Market Size 2016-2020, by Country, in USD Million

50. Table South America Pulmonary Hypertension Drugs Market Size 2016-2020, by Country, in Volume

51. Table Middle East & Africa Pulmonary Hypertension Drugs Market Size 2016-2020, by Country, in USD Million

52. Table Middle East & Africa Pulmonary Hypertension Drugs Market Size 2016-2020, by Country, in Volume

53. Table Pulmonary Hypertension Drugs Market Forecast 2021-2026, by Region, in USD Million

54. Table Pulmonary Hypertension Drugs Market Forecast 2021-2026, by Region, in Volume

55. Table Price Factors List

List of Figure

1. Figure Pulmonary Hypertension Drugs Industry Chain Structure

2. Figure Global Pulmonary Hypertension Drugs Market Growth 2016-2020, by Type, in USD Million

3. Figure Global Pulmonary Hypertension Drugs Market Growth 2016-2020, by Type, in Volume

4. Figure Global Pulmonary Hypertension Drugs Sales Revenue Share in 2020, by Company, in USD Million

5. Figure Global Pulmonary Hypertension Drugs Sales Volume Share in 2020, by Company, in Volume

6. Figure North America Pulmonary Hypertension Drugs Market Concentration, in 2020

7. Figure Europe Pulmonary Hypertension Drugs Market Market Concentration, in 2020

8. Figure Asia-Pacific Pulmonary Hypertension Drugs MMarket Concentration, in 2020

9. Figure South America Pulmonary Hypertension Drugs Market Concentration, in 2020

10. Figure Middle East & Africa Pulmonary Hypertension Drugs Market Concentration, in 2020

11. Figure Pulmonary Hypertension Drugs Demand in Early-stage Drug Candidates (Phase I & Phase II), 2016-2020, in USD Million

12. Figure Pulmonary Hypertension Drugs Demand in Early-stage Drug Candidates (Phase I & Phase II), 2016-2020, in Volume

13. Figure Pulmonary Hypertension Drugs Demand in Late-stage Drug Candidates (Phase III & Registration Phase), 2016-2020, in USD Million

14. Figure Pulmonary Hypertension Drugs Demand in Late-stage Drug Candidates (Phase III & Registration Phase), 2016-2020, in Volume

15. Figure Pulmonary Hypertension Drugs Market Growth 2021-2026, by Application, in USD Million

16. Figure Pulmonary Hypertension Drugs Market Share in 2026, by Application, in USD Million

17. Figure North America Pulmonary Hypertension Drugs Market Size and Growth 2016-2020, in USD Million

18. Figure North America Pulmonary Hypertension Drugs Market Size and Growth 2016-2020, in Volume

19. Figure Europe Pulmonary Hypertension Drugs Market Size and Growth 2016-2020, in USD Million

20. Figure Europe Pulmonary Hypertension Drugs Market Size and Growth 2016-2020, in Volume

21. Figure Asia-Pacific Pulmonary Hypertension Drugs Market Size and Growth 2016-2020, in USD Million

22. Figure Asia-Pacific Pulmonary Hypertension Drugs Market Size and Growth 2016-2020, in Volume

23. Figure South America Pulmonary Hypertension Drugs Market Size and Growth 2016-2020, in USD Million

24. Figure South America Pulmonary Hypertension Drugs Market Size and Growth 2016-2020, in Volume

25. Figure Middle East & Africa Pulmonary Hypertension Drugs Market Size and Growth 2016-2020, in USD Million

26. Figure Middle East & Africa Pulmonary Hypertension Drugs Market Size and Growth 2016-2020, in Volume

27. Figure Marketing Channels Overview

If you have any special requirements, please let us know and we will offer you the report as you want.

Please share youre basic details, to recieve the report sample

If you have any special requirements, please let us know and we will offer you the report as you want.

Our Clients

dropbox
kodak
honeywell
philips
nestle
Hanwha
Compass-Minerals
Elanco
Honda-Europe
Courant.Biz | Powered By SAIME DIGITAL TECHNOLOGIES PVT. LTD. | © 2020